Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease

Tuber Lung Dis. 1994 Jun;75(3):179-80. doi: 10.1016/0962-8479(94)90003-5.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • BCG Vaccine* / adverse effects
  • Child, Preschool
  • Humans
  • Immunization Programs*
  • Infant
  • Infant, Newborn
  • Prevalence
  • Tuberculosis / epidemiology
  • Tuberculosis / prevention & control*
  • Tuberculosis, Meningeal / epidemiology
  • Tuberculosis, Pulmonary / epidemiology

Substances

  • BCG Vaccine